Ad is loading...
CMEUX
Price
$20.80
Change
-$0.33 (-1.56%)
Updated
Nov 15 closing price
RWMEX
Price
$63.76
Change
-$0.73 (-1.13%)
Updated
Nov 15 closing price
Ad is loading...

CMEUX vs RWMEX

Header iconCMEUX vs RWMEX Comparison
Open Charts CMEUX vs RWMEXBanner chart's image
Six Circles Mgd Eq Port US Uncons
Price$20.80
Change-$0.33 (-1.56%)
VolumeN/A
CapitalizationN/A
American Funds Washington Mutual R4
Price$63.76
Change-$0.73 (-1.13%)
VolumeN/A
CapitalizationN/A
CMEUX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMEUX vs. RWMEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMEUX is a Buy and RWMEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 191B vs. CMEUX (18.2B). RWMEX pays higher dividends than CMEUX: RWMEX (1.45) vs CMEUX (1.05). CMEUX was incepted earlier than RWMEX: CMEUX (6 years) vs RWMEX (23 years). CMEUX is a more actively managed with annual turnover of: 49.13 vs. RWMEX (30.00). CMEUX has a lower initial minimum investment than RWMEX: CMEUX (0) vs RWMEX (250). CMEUX annual gain was more profitable for investors over the last year : 31.29 vs. RWMEX (18.03). CMEUX return over 5 years is better than : 105.87 vs. RWMEX (37.76).
CMEUXRWMEXCMEUX / RWMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years23 years-
Gain YTD24.25313.377181%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets18.2B191B10%
Annual Yield % from dividends1.051.4572%
Returns for 1 year31.2918.03173%
Returns for 3 years24.3410.11241%
Returns for 5 years105.8737.76280%
Returns for 10 yearsN/A56.39-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY23.561.17
+5.23%
Lifeway Foods
NOAH11.720.31
+2.72%
Noah Holdings Limited
PEG88.991.99
+2.29%
Public Service Enterprise Group
ANTX1.00N/A
N/A
AN2 Therapeutics
DNB12.12-0.18
-1.46%
Dun & Bradstreet Holdings